| [1] |
陈琼, 方杰, 魏强华. 系统性红斑狼疮合并纯红细胞再生障碍性贫血1例报道及文献复习[J]. 上海交通大学学报(医学版), 2024, 44(2): 278-286.
|
|
CHEN Q, FANG J, WEI Q H. Systemic lupus erythematosus complicated with pure red cell aplasia: a case report and literature review[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(2): 278-286.
|
| [2] |
DEZERN A E, CHURPEK J E. Approach to the diagnosis of aplastic anemia[J]. Blood Adv, 2021, 5(12): 2660-2671.
|
| [3] |
DUAN S G, YU Y, GUO Y C, et al. Epidemiological evaluation of Bacillus cereus-induced foodborne outbreaks: China, 2010‒2020[J]. China CDC Wkly, 2023, 5(33): 737-741.
|
| [4] |
SCOPPAPIETRA L, AUDINO A, RICCIARDELLI G, et al. A fatal rhabdomyolysis with the presence of Bacillus cereus on blood culture: description of a clinical case[J]. Microbiol Med, 2024, 39(1): 12419.
|
| [5] |
SHIMADA T, ISHIKAWA K, KAWAI F, et al. Risk factors associated with infection-related mortality of Bacillus cereus bacteremia in hematologic disorders[J]. Int J Hematol, 2023, 118(6): 726-730.
|
| [6] |
LITTLE J S, COUGHLIN C, HSIEH C, et al. Neuroinvasive Bacillus cereus infection in immunocompromised hosts: Epidemiologic investigation of 5 patients with acute myeloid leukemia[J]. Open Forum Infect Dis, 2024, 11(3): ofae048.
|
| [7] |
HUANG L F, LI L, JIA J S, et al. Frontline therapy options for adults with newly diagnosed severe aplastic anemia: intensive immunosuppressive therapy plus eltrombopag or matched sibling donor hematopoietic stem cell transplantation?[J]. Transplant Cell Ther, 2022, 28(9): 586.e1-586.e7.
|
| [8] |
LI X L, SHANGGUAN X H, WANG H, et al. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence[J]. Ann Hematol, 2024, 103(9): 3483-3491.
|
| [9] |
SUN S, XU Z Y, HU H J, et al. The Bacillus cereus toxin alveolysin disrupts the intestinal epithelial barrier by inducing microtubule disorganization through CFAP100[J]. Sci Signal, 2023, 16(785): eade8111.
|
| [10] |
ENOSI TUIPULOTU D, MATHUR A, NGO C, et al. Bacillus cereus: epidemiology, virulence factors, and host-pathogen interactions[J]. Trends Microbiol, 2021, 29(5): 458-471.
|
| [11] |
OKUTANI A, OKUGAWA S, FUJIMOTO F, et al. Genetic diversity and virulence of Bacillus cereus group isolates from bloodstream infections[J]. Microbiol Spectr, 2025, 13(3): e0240724.
|
| [12] |
毛原飞, 游建华, 张莉娜, 等. 恶性血液病化疗后粒细胞缺乏期医院感染危险因素的分析[J]. 上海交通大学学报(医学版),2014, 34(1): 60-64.
|
|
MAO Y F, YOU J H, ZHANG L N, et al. Risk factors for nosocomial infection in agranulocytosis patients after chemotherapy to hematological malignancy[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2014, 34(1): 60-64.
|
| [13] |
HIDALGO A, LIBBY P, SOEHNLEIN O, et al. Neutrophil extracellular traps: from physiology to pathology[J]. Cardiovasc Res, 2022, 118(13): 2737-2753.
|
| [14] |
MURSALIN M H, LIVINGSTON E T, CALLEGAN M C. The Cereus matter of Bacillus endophthalmitis[J]. Exp Eye Res, 2020, 193: 107959.
|
| [15] |
MEI F, LIN J Q, LIU M L, et al. Posttraumatic Bacillus cereus endophthalmitis: clinical characteristics and antibiotic susceptibilities[J]. J Ophthalmol, 2021, 2021: 6634179.
|
| [16] |
BOUSTANY A, RAMAHI N, HINDY J R, et al. Persistent Bacillus cereus bacteremia in an immunocompetent patient with a history of polysubstance abuse[J]. Cureus, 2023, 15(1): e33650.
|
| [17] |
金磊, 徐文彬, 叶晨静, 等. 泊沙康唑对血液恶性肿瘤化疗患者的预防性抗真菌作用[J]. 上海交通大学学报(医学版), 2022, 42(6): 792-796.
|
|
JIN L, XU W B, YE C J, et al. Prophylactic antifungal effect of posaconazole on patients with hematological malignant tumor undergoing chemotherapy[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 792-796.
|